Trial intelligence / Profile preview

Ilomedin in STEMI Patients After Primary PCI

NCT01179776Phase 2Completed

Sponsor
Thrombologic
Start
Sep 2010
Primary completion
May 2011
Countries
1
01

Overview

A Phase 2 trial of iloprost in myocardial infarction (MI), sponsored by Thrombologic. Started Sep 2010; status: completed.

02

Drugs

iloprost
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT01179776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01179776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call